Effect of Romosozumab Treatment in Postmenopausal Women With Osteoporosis and Knee Osteoarthritis: Results From a Substudy of a Phase 3 Clinical Trial.

Nancy E LaneDonald BetahCynthia DeignanMary OatesZhenxun WangJen TimoshankoAliya A KhanNeil Binkley

Published in: ACR open rheumatology (2023)

Romosozumab treatment did not impact knee pain or function in postmenopausal women with osteoporosis and knee osteoarthritis and resulted in significant BMD gains in these women.

Keyphrases

knee osteoarthritis
bone mineral density
clinical trial
postmenopausal women
chronic pain
type diabetes
randomized controlled trial
spinal cord injury
pregnant women
body composition
open label